Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (36)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kretzschmar, M.
Right arrow Articles by Postma, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kretzschmar, M.
Right arrow Articles by Postma, M. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Vol. 153, No. 1 : 90-101
Copyright © 2001 by The Johns Hopkins University School of Hygiene and Public Health


ORIGINAL CONTRIBUTIONS

Comparative Model-based Analysis of Screening Programs for Chlamydia trachomatis Infections

Mirjam Kretzschmar1, Robert Welte2,4, Anneke van den Hoek3 and Maarten J. Postma4,5

1 Department of Infectious Disease Epidemiology, National Institute of Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
2 Department of Health Economics, University of Ulm, Ulm, Germany.
3 Municipal Health Service, Amsterdam, Department of Public Health and Environment, Amsterdam, the Netherlands.
4 Department for Health Services Research, National Institute of Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
5 Groningen University Institute of Drug Exploration (GUIDE), University of Groningen, Groningen, the Netherlands.

The design of a screening program for asymptomatic genital infections with Chlamydia trachomatis, requires decisions about which sex or age group should be targeted and whether partner referral should be included in the program. To investigate the effects of various screening programs on the prevalence and incidence of asymptomatic C. trachomatis infections in women, in May 1996 to April 1997 in Bilthoven, the Netherlands, the authors used a stochastic simulation model for C. trachomatis transmission in an age-structured, heterosexual population with a sexually highly active core group. Different screening scenarios were implemented over a time period of 10 years. Prevalence, incidence, and the fraction of infected persons found by partner referral were computed. Through screening of men and women between ages 15 and 24 years (baseline scenario), the prevalence of asymptomatic infections in women could be reduced from 4.2% to 1.4% in 10 years. Increasing the age range of screening up to ages 29 or 34 years led to prevalences of 0.4% and 0.06%, respectively, after 10 years. About 28% of all infected persons were found via partner referral. There are considerable indirect positive effects of screening on those population groups that are not included in the screening because of the reduced risk of becoming infected. Partner referral contributes substantially to prevalence reduction.

Chlamydia trachomatis

Abbreviations: LCR, ligase chain reaction; PCR, polymerase chain reaction; PID, pelvic inflammatory disease; STD, sexually transmitted disease.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Sex. Transm. Infect.Home page
M Kretzschmar, K M E Turner, P M Barton, W J Edmunds, and N Low
Predicting the population impact of chlamydia screening programmes: comparative mathematical modelling study
Sex Transm Inf, September 1, 2009; 85(5): 359 - 366.
[Abstract] [Full Text] [PDF]


Home page
Sex. Transm. Infect.Home page
A M Foss, P T Vickerman, M Alary, and C H Watts
How much could a microbicide's sexually transmitted infection efficacy contribute to reducing HIV risk and the level of condom use needed to lower risk? Model estimates
Sex Transm Inf, August 1, 2009; 85(4): 276 - 282.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
T. E Roberts, S. Robinson, P. M Barton, S. Bryan, A. McCarthy, J. Macleod, M. Egger, and N. Low
Cost effectiveness of home based population screening for Chlamydia trachomatis in the UK: economic evaluation of chlamydia screening studies (ClaSS) project
BMJ, August 11, 2007; 335(7614): 291 - 291.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
S. D. Datta, M. Sternberg, R. E. Johnson, S. Berman, J. R. Papp, G. McQuillan, and H. Weinstock
Gonorrhea and Chlamydia in the United States among Persons 14 to 39 Years of Age, 1999 to 2002
Ann Intern Med, July 17, 2007; 147(2): 89 - 96.
[Abstract] [Full Text] [PDF]


Home page
Sex. Transm. Infect.Home page
K M E Turner, E J Adams, D S LaMontagne, L Emmett, K Baster, and W J Edmunds
Modelling the effectiveness of chlamydia screening in England
Sex Transm Inf, December 1, 2006; 82(6): 496 - 502.
[Abstract] [Full Text] [PDF]


Home page
Sex. Transm. Infect.Home page
J R Williams, A M Foss, P Vickerman, C Watts, B M Ramesh, S Reza-Paul, R G Washington, S Moses, J Blanchard, C M Lowndes, et al.
What is the achievable effectiveness of the India AIDS Initiative intervention among female sex workers under target coverage? Model projections from southern India.
Sex Transm Inf, October 1, 2006; 82(5): 372 - 380.
[Abstract] [Full Text] [PDF]


Home page
Sex. Transm. Infect.Home page
P Vickerman, C Watts, R W Peeling, D Mabey, and M Alary
Modelling the cost effectiveness of rapid point of care diagnostic tests for the control of HIV and other sexually transmitted infections among female sex workers.
Sex Transm Inf, October 1, 2006; 82(5): 403 - 412.
[Abstract] [Full Text] [PDF]


Home page
Sex. Transm. Infect.Home page
T E Roberts, S Robinson, P Barton, S Bryan, N Low, and for the Chlamydia Screening Studies (ClaSS) Group
Screening for Chlamydia trachomatis: a systematic review of the economic evaluations and modelling.
Sex Transm Inf, June 1, 2006; 82(3): 193 - 200.
[Abstract] [Full Text] [PDF]


Home page
Sex. Transm. Infect.Home page
S M Berman and R E Johnson
Commentary.
Sex Transm Inf, April 1, 2006; 82(2): 152 - 153.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
D. Hu, E. W. Hook III, and S. J. Goldie
Screening for Chlamydia trachomatis in Women 15 to 29 Years of Age: A Cost-Effectiveness Analysis
Ann Intern Med, October 5, 2004; 141(7): 501 - 513.
[Abstract] [Full Text] [PDF]


Home page
Sex. Transm. Infect.Home page
D S LaMontagne, K A Fenton, S Randall, S Anderson, P Carter, and on behalf of the National Chlamydia Screening Stee
Establishing the National Chlamydia Screening Programme in England: results from the first full year of screening
Sex Transm Inf, October 1, 2004; 80(5): 335 - 341.
[Abstract] [Full Text] [PDF]


Home page
Sex. Transm. Infect.Home page
P Vickerman, C Watts, M Alary, D Mabey, and R W Peeling
Sensitivity requirements for the point of care diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae in women
Sex Transm Inf, October 1, 2003; 79(5): 363 - 367.
[Abstract] [Full Text] [PDF]


Home page
Sex. Transm. Infect.Home page
R Welte, M Kretzschmar, J A R van den Hoek, and M J Postma
A population based dynamic approach for estimating the cost effectiveness of screening for Chlamydia trachomatis
Sex Transm Inf, October 1, 2003; 79(5): 426 - 426.
[Full Text]


Home page
Sex. Transm. Infect.Home page
V Verhoeven, D Avonts, A Meheus, H Goossens, M Ieven, S Chapelle, C Lammens, and P Van Royen
Chlamydial infection: an accurate model for opportunistic screening in general practice
Sex Transm Inf, August 1, 2003; 79(4): 313 - 317.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.